UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Compare cheap dividend ETFs to identify which has the best yield, balancing income with cost. Explore top contenders and make an informed choice.
27,900 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Two defense giants report stronger 2025 results as budgets rise. Lockheed Martin turns around its Missiles & Fire Con...
A sudden 17% intraday surge in Brady Corporation has investors buzzing. This piece breaks down how AI-linked demand f...
Investors are torn between rate hikes and rate cuts as inflation stays stubborn. Wall Street can't decide the Fed's p...
Choosing the right index fund in retirement matters more than most people realize. This guide breaks down SP500 vs to...
Gold tumbles after the Federal Reserve narrows its rate-cut outlook, sliding from the $5,000 zone to around $4,500. T...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
Spotlighting two strong growth names that could exceed Summit Therapeutics in a year. Learn the catalysts, risks, and...
Bank of America stock just surged to a record high as investors await quarterly results. This guide breaks down what ...
Nvidia just landed a significant AI deal that could shift its growth trajectory. This article breaks down what invest...
Two leading travel platforms, Booking Holdings and Airbnb, each chart different revenue paths. This article breaks do...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...